Innova Care Concepts expand their support to the medical negligence sector with the acquisition of Nurture Group Ltd.
April 5, 2023Business Services
Press Release, Wednesday 5th April 2023, London… As part of a long-term strategy to increase its home adaptation services across …
Ipsen’s response to NICE’s decision on Cabometyx® (cabozantinib) for previously treated differentiated thyroid cancer unsuitable for or refractory to radioactive iodine
April 5, 2023Business Services
SLOUGH, UK, 5th April 2023 – Ipsen is disappointed that the National Institute for Health and Care Excellence (NICE) …
Syncona Appoints Roel Bulthuis as Managing Partner
April 5, 2023Business Services
05 April 2023 Syncona Ltd, a leading healthcare company focused on creating, building and scaling global leaders in life …
First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Study
April 5, 2023Business Services
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …
BenevolentAI announces top-line Phase IIa results for its topical pan-Trk inhibitor BEN-2293 (1%) in mild-to-moderate atopic dermatitis
April 5, 2023Business Services
London, UK, 5 April 2023: BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI) announces top-line results from its Phase IIa, …
AstraZeneca reports positive results of drug combination in late-stage ovarian cancer trial
April 5, 2023Medical Communications
AstraZeneca has announced positive high-level results from an interim analysis of the DUO-O phase 3 trial assessing a combination of …
FDA requires prepaid mail-back envelopes for opioid analgesics
April 5, 2023Medical Communications
The FDA has announced that it will require opioid analgesic manufacturers to provide prepaid mail-back envelopes in outpatient pharmacies and …
Phlo acquires Truepill UK in landmark digital pharmacy consolidation
April 4, 2023Business Services
Glasgow, UK. Phlo Technologies UK digital pharmacy leaders, have today announced their acquisition of the UK arm of US-based healthcare …
Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO
April 4, 2023Business Services
Cambridge, UK, 04 April 2023 – Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company dedicated to resolving …
Recipharm bolsters senior leadership team with appointment of Joaquim Mascaro as Chief Financial Officer
April 4, 2023Business Services
Global contract development and manufacturing organisation (CDMO) Recipharm, has announced the appointment of Joaquim Mascaro as Chief Financial Officer.
Optibrium Appoints Computational Modelling Expert, Dr Hamed Tabatabaei Ghomi as Head of Research
April 4, 2023Business Services
Appointment will lead research strategy to apply the latest scientific innovations to Optibrium’s computational and AI drug discovery technologies Hamed …
Landmark data published on successful NTCD-M3 gut colonisation after fidaxomicin administration
April 4, 2023Business Services
Brighton, United Kingdom – 4 April 2023 – Destiny Pharma (AIM: DEST), a clinical stage innovative biotechnology company focused on …
PHARMANOVIA RECEIVES SBTi APPROVAL FOR NET ZERO EMISSION TARGETS
April 4, 2023Business Services
Basildon, UK, 3 April 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already established …
Ingenza appoints Steve Jones as its new Chief Financial Officer
April 4, 2023Business Services Ingenza
Ingenza appoints Steve Jones as its new Chief Financial Officer
Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals
April 4, 2023Business Services
New Jersey, USA, and Oxford, UK, 3rd April 2023: Evergreen Discovery (Evergreen), a leading radiopharmaceutical drug development company with a …
Vertex Pharmaceuticals and CRISPR Therapeutics submit FDA rolling Biologics License Applications for gene editing-based medicine
April 4, 2023Research and Development
US-based Vertex Pharmaceuticals and Swiss CRISPR Therapeutics have announced the completion of their rolling Biologics License Applications (BLAs) to the …
FDA publishes report stating Global Pharma’s eye drops broke safety norms
April 4, 2023Medical Communications
The FDA has published a report revealing that Global Pharma’s plant in India’s Chennai city failed to achieve safety norms …
InnoCare announced first subject dosed in clinical trial of novel targeted protein degrader ICP-490
April 4, 2023Medical Communications
InnoCare has announced that the first subject has been dosed in its clinical trial of its novel targeted protein degrader …
Merck receives FDA approval for Keytruda in combination with Padcev to treat bladder cancer
April 4, 2023Medical Communications
Merck (known as MSD globally) has announced that it has received FDA approval for Keytruda in combination with Padcev for …
Théa Open Innovation and Galimedix announce partnership for development and commercialisation of GAL-101
April 3, 2023Sales and Marketing
Théa Open Innovation (TOI) and Galimedix have announced that they have signed a licensing agreement granting TOI exclusive rights for …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
